ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 185 filers reported holding ACCELERON PHARMA INC in Q4 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $19,183,000 | +296.8% | 111,461 | +189.3% | 0.01% | +350.0% |
| Q2 2021 | $4,834,000 | +17.4% | 38,524 | +26.9% | 0.00% | 0.0% |
| Q1 2021 | $4,117,000 | +328.4% | 30,363 | +303.9% | 0.00% | +100.0% |
| Q4 2020 | $961,000 | +198.4% | 7,517 | +162.0% | 0.00% | – |
| Q3 2020 | $322,000 | -74.3% | 2,869 | -78.2% | 0.00% | -100.0% |
| Q2 2020 | $1,252,000 | -69.3% | 13,140 | -71.1% | 0.00% | -66.7% |
| Q1 2020 | $4,082,000 | -49.0% | 45,425 | -69.9% | 0.00% | -25.0% |
| Q4 2019 | $7,999,000 | +89.0% | 150,876 | +40.8% | 0.00% | +100.0% |
| Q3 2019 | $4,233,000 | +79.4% | 107,146 | +86.6% | 0.00% | +100.0% |
| Q2 2019 | $2,359,000 | -64.6% | 57,426 | -59.8% | 0.00% | -80.0% |
| Q1 2019 | $6,657,000 | +1022.6% | 142,967 | +950.7% | 0.01% | – |
| Q4 2018 | $593,000 | -61.9% | 13,607 | -49.9% | 0.00% | -100.0% |
| Q3 2018 | $1,555,000 | -68.8% | 27,183 | -73.5% | 0.00% | -75.0% |
| Q2 2018 | $4,978,000 | +119.1% | 102,603 | +76.6% | 0.00% | +100.0% |
| Q1 2018 | $2,272,000 | +794.5% | 58,105 | +872.6% | 0.00% | – |
| Q4 2017 | $254,000 | -14.2% | 5,974 | -24.8% | 0.00% | – |
| Q3 2017 | $296,000 | +9766.7% | 7,944 | +10782.2% | 0.00% | – |
| Q2 2017 | $3,000 | -93.8% | 73 | -95.9% | 0.00% | – |
| Q1 2017 | $48,000 | -88.1% | 1,794 | -88.6% | 0.00% | – |
| Q4 2016 | $403,000 | +256.6% | 15,792 | +407.9% | 0.00% | – |
| Q3 2016 | $113,000 | +11200.0% | 3,109 | +7482.9% | 0.00% | – |
| Q2 2016 | $1,000 | -98.5% | 41 | -98.4% | 0.00% | – |
| Q1 2016 | $66,000 | +187.0% | 2,514 | +413.1% | 0.00% | – |
| Q4 2015 | $23,000 | -90.3% | 490 | -95.0% | 0.00% | – |
| Q3 2015 | $236,000 | +1715.4% | 9,861 | +2231.2% | 0.00% | – |
| Q2 2015 | $13,000 | -53.6% | 423 | -42.0% | 0.00% | – |
| Q1 2015 | $28,000 | -51.7% | 729 | -51.9% | 0.00% | – |
| Q4 2014 | $58,000 | +866.7% | 1,515 | +673.0% | 0.00% | – |
| Q3 2014 | $6,000 | -45.5% | 196 | -42.5% | 0.00% | – |
| Q2 2014 | $11,000 | +37.5% | 341 | +42.7% | 0.00% | – |
| Q1 2014 | $8,000 | -33.3% | 239 | -21.9% | 0.00% | – |
| Q4 2013 | $12,000 | – | 306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |